[DNLI] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[DNLI] Denali Therapeutics Inc.
Announcement Date
03-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -75.70%
YoY- -22.12%
Quarter Report
DNLI's Result
DNLI's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 294,123 35,141 10,283 3,559 52,480 42,141 12,514 725.27%
PBT 183,383 -109,781 -98,684 -103,299 -58,767 -65,220 -75,836 -
Tax -2,285 -10,047 -6 2,114 27 -1,278 -575 151.52%
NP 183,383 -109,781 -98,678 -103,299 -58,794 -63,942 -75,261 -
Tax Rate 1.25% - - - - - - -
Total Cost 110,740 144,922 108,961 106,858 111,274 106,083 87,775 16.80%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 62.35 -312.40 -959.62 -2,902.47 -112.03 -151.73 -601.41 -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS 1.34 -0.80 -0.74 -0.84 -0.48 -0.52 -0.62 -
EPS Diluted 1.30 -0.80 -0.74 -0.84 -0.48 -0.52 -0.62 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.